Market Closed -
Bombay S.E.
11:01:02 05/07/2024 BST
|
5-day change
|
1st Jan Change
|
46.59
INR
|
+1.93%
|
|
+0.52%
|
-6.93%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
150.8
|
142.4
|
161.6
|
267.8
|
1,526
|
2,395
|
Enterprise Value (EV)
1 |
294
|
305.7
|
313.5
|
281.6
|
1,535
|
2,399
|
P/E ratio
|
21.6
x
|
-7.66
x
|
-2.78
x
|
-15.1
x
|
33.7
x
|
77
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.14
x
|
0.16
x
|
0.22
x
|
0.41
x
|
1.17
x
|
1.03
x
|
EV / Revenue
|
0.27
x
|
0.35
x
|
0.42
x
|
0.43
x
|
1.18
x
|
1.03
x
|
EV / EBITDA
|
7.06
x
|
-3,727
x
|
-6.74
x
|
49.8
x
|
17.4
x
|
34.1
x
|
EV / FCF
|
19.2
x
|
-38.2
x
|
-1.95
x
|
9.45
x
|
-12.1
x
|
-15.1
x
|
FCF Yield
|
5.2%
|
-2.62%
|
-51.2%
|
10.6%
|
-8.29%
|
-6.63%
|
Price to Book
|
1.59
x
|
1.58
x
|
2.64
x
|
3.86
x
|
6.84
x
|
4.2
x
|
Nbr of stocks (in thousands)
|
16,210
|
18,790
|
21,540
|
23,290
|
31,890
|
39,863
|
Reference price
2 |
9.300
|
7.580
|
7.500
|
11.50
|
47.84
|
60.08
|
Announcement Date
|
27/01/20
|
31/10/20
|
03/08/21
|
25/08/22
|
28/08/23
|
05/07/24
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net sales
1 |
1,097
|
881
|
746.4
|
656.3
|
1,306
|
2,335
|
EBITDA
1 |
41.63
|
-0.082
|
-46.53
|
5.652
|
88.47
|
70.4
|
EBIT
1 |
20.16
|
-21.58
|
-70.08
|
-20.15
|
61.45
|
42.51
|
Operating Margin
|
1.84%
|
-2.45%
|
-9.39%
|
-3.07%
|
4.71%
|
1.82%
|
Earnings before Tax (EBT)
1 |
15.03
|
-22
|
-73.15
|
-21.73
|
61.51
|
41.13
|
Net income
1 |
7.524
|
-18.53
|
-55.66
|
-17.07
|
45.13
|
27.61
|
Net margin
|
0.69%
|
-2.1%
|
-7.46%
|
-2.6%
|
3.46%
|
1.18%
|
EPS
2 |
0.4300
|
-0.9900
|
-2.700
|
-0.7600
|
1.420
|
0.7800
|
Free Cash Flow
1 |
15.29
|
-8.009
|
-160.5
|
29.8
|
-127.3
|
-159.1
|
FCF margin
|
1.39%
|
-0.91%
|
-21.51%
|
4.54%
|
-9.75%
|
-6.81%
|
FCF Conversion (EBITDA)
|
36.72%
|
-
|
-
|
527.26%
|
-
|
-
|
FCF Conversion (Net income)
|
203.19%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
27/01/20
|
31/10/20
|
03/08/21
|
25/08/22
|
28/08/23
|
05/07/24
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net Debt
1 |
143
|
163
|
152
|
13.7
|
9.47
|
3.53
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.44
x
|
-1,991
x
|
-3.265
x
|
2.426
x
|
0.1071
x
|
0.0502
x
|
Free Cash Flow
1 |
15.3
|
-8.01
|
-161
|
29.8
|
-127
|
-159
|
ROE (net income / shareholders' equity)
|
7.13%
|
-16.8%
|
-65%
|
-24.3%
|
30.9%
|
6.97%
|
ROA (Net income/ Total Assets)
|
2.11%
|
-2.17%
|
-6.27%
|
-1.84%
|
5.04%
|
2.07%
|
Assets
1 |
357.1
|
854.4
|
887.1
|
928.3
|
896.2
|
1,334
|
Book Value Per Share
2 |
5.870
|
4.800
|
2.840
|
2.980
|
6.990
|
14.30
|
Cash Flow per Share
2 |
0.1700
|
0.0700
|
0.0100
|
0.0100
|
0.1800
|
0.0200
|
Capex
1 |
10.5
|
34.4
|
51.1
|
44.1
|
19.6
|
66.8
|
Capex / Sales
|
0.96%
|
3.9%
|
6.84%
|
6.72%
|
1.5%
|
2.86%
|
Announcement Date
|
27/01/20
|
31/10/20
|
03/08/21
|
25/08/22
|
28/08/23
|
05/07/24
|
|
1st Jan change
|
Capi.
|
---|
| -6.93% | 22.24M | | +8.91% | 79.91B | | -7.50% | 43.6B | | +2.68% | 33.03B | | +14.17% | 18.88B | | +5.21% | 11.11B | | -23.10% | 10B | | -10.03% | 9.66B | | -2.94% | 8.7B | | +5.22% | 8.05B |
Diversified Chemicals
|